The Pharma-Psych Nexus
The expression pharma-psych nexus (Williams, Katz, and Martin 2011) has been used to capture the spread of psychopharmaceutical products that target the brain’s chemistry.
This includes, among others, the commercialization of selective serotonin reuptake inhibitors (SSRIs) for depression and anxiety-related disorders and of psychostimulants like methylphenidate (well known under the trade name Ritalin) for ADHD as well as the use of these and other substances, such as modafinil (indicated for the treatment of narcolepsy), for recreational and enhancement purposes.
Download the article by Williams, Katz and Martin below:Williams, J. Simon, Stephen Katz, and Paul Martin. 2011. The NeuroComplex: Some Comments and Converg...